Drugs / DENV-1 PIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01502735 | Dec 2011 → Sep 2013 | dengue disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DENV-1 PIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01502735 ↗ |
| Modality | Vaccine | “This is a phase 1 study to evaluate the safety of a vaccine (DENV-1 PIV) for the prevention of dengue fever.” NCT01502735 ↗ |
| Route | Intramuscular | “administered via intramuscular injection” NCT01502735 ↗ |